BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34727240)

  • 1. Do Minimally Invasive Benign Prostatic Hyperplasia Treatments Preserve Sexual Function? A Contemporary Review of the Literature.
    Kim J; Polchert M; Chacko B; Tannenbaum J; Raheem O
    Curr Urol Rep; 2021 Nov; 22(11):56. PubMed ID: 34727240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
    Tanneru K; Jazayeri SB; Alam MU; Kumar J; Bazargani S; Kuntz G; Palayapalayam Ganapathi H; Bandyk M; Marino R; Koochekpour S; Gautam S; Balaji KC; Costa J
    J Endourol; 2021 Apr; 35(4):409-416. PubMed ID: 32962442
    [No Abstract]   [Full Text] [Related]  

  • 3. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains.
    Ng BHS; Chung E
    Investig Clin Urol; 2021 Mar; 62(2):148-158. PubMed ID: 33660441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Sexual Preservation After Novel Benign Prostatic Hyperplasia Surgical Treatment Modalities From Food and Drug Administration Clinical Trials.
    Bhojani N; Yafi FA; Misrai V; Rijo E; Chughtai B; Zorn KC; Elterman D
    Sex Med Rev; 2021 Jan; 9(1):169-173. PubMed ID: 33309271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Surgery for Benign Prostatic Hyperplasia on Sexual Function: A Systematic Review and Meta-analysis of Erectile Function and Ejaculatory Function.
    Manfredi C; García-Gómez B; Arcaniolo D; García-Rojo E; Crocerossa F; Autorino R; Gratzke C; De Sio M; Romero-Otero J
    Eur Urol Focus; 2022 Nov; 8(6):1711-1732. PubMed ID: 35803852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office-Based Procedures for BPH.
    Gao B; Lu S; Bhojani N; Zorn KC; Chughtai B; Elterman D
    Curr Urol Rep; 2021 Dec; 22(12):63. PubMed ID: 34913101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UroLift and Rezum: minimally invasive surgical therapies for the management of benign prostatic hyperplasia.
    Leong JY; Tokarski AT; Roehrborn CG; Das AK
    Can J Urol; 2021 Aug; 28(S2):2-5. PubMed ID: 34453421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update.
    Dornbier R; Pahouja G; Branch J; McVary KT
    Curr Urol Rep; 2020 Jul; 21(9):32. PubMed ID: 32607874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to offer True Minimally Invasive Treatments (TMIST) for BPH? - A review of office-based therapies and introduction of a new technology category.
    Elterman DS; Zorn KC; Chughtai B; Bhojani N
    Can J Urol; 2021 Apr; 28(2):10580-10583. PubMed ID: 33872553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia.
    McVary KT; El-Arabi A; Roehrborn C
    Sex Med; 2021 Dec; 9(6):100454. PubMed ID: 34731779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of Reported Ejaculatory Dysfunction in Clinical Trials Evaluating Minimally Invasive Treatment Modalities for BPH.
    Lokeshwar SD; Valancy D; Lima TFN; Blachman-Braun R; Ramasamy R
    Curr Urol Rep; 2020 Oct; 21(12):54. PubMed ID: 33104947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and Aquablation.
    Bilhim T; Betschart P; Lyatoshinsky P; Müllhaupt G; Abt D
    Cardiovasc Intervent Radiol; 2022 Apr; 45(4):415-424. PubMed ID: 35043243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review.
    Porto JG; Arbelaez MCS; Blachman-Braun R; Bhatia A; Bhatia S; Satyanarayana R; Marcovich R; Shah HN
    World J Urol; 2023 Jul; 41(7):1975-1982. PubMed ID: 37222779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review.
    Abid A; Piperdi H; Babar M; Loloi J; Moutwakil A; Azhar U; Maria P; Small A
    Prostate; 2024 Jul; 84(10):895-908. PubMed ID: 38656693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
    De Nunzio C; Cantiello F; Fiori C; Crocerossa F; Tognoni P; Amparore D; Baldassarri V; Elbers JR; Sancha FG; Porpiglia F
    World J Urol; 2021 Jun; 39(6):2037-2042. PubMed ID: 32851439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.